Mechanisms of Cyclosporine A Inhibition of Antigen-Presenting Activity in Uninvolved and Lesional Psoriatic Epidermis
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 94 (5), 649-656
- https://doi.org/10.1111/1523-1747.ep12876222
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Induction of IL-2 receptor expression in vivo: Response to concanavalin ACellular Immunology, 1988
- Dose response and time course for induction of T6− DR + human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiationJournal of the American Academy of Dermatology, 1987
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987
- INHIBITION OF HUMAN MONOCYTE ANTIGEN PRESENTATION, BUT NOT HLA-DR EXPRESSION, BY CYCLOSPORINETransplantation, 1987
- Psoriasis, cyclosporin A, and AIDS.BMJ, 1987
- Different In Situ Distribution Patterns of Dendritic Cells Having Langerhans (T6+) and Interdigitating (RFD1+) Cell Immunophenotype in Psoriasis, Atopic Dermatitis, and Other Inflammatory DermatosesJournal of Investigative Dermatology, 1986
- SENSITIVITY OF VEILED (DENDRITIC) CELLS TO CYCLOSPORINETransplantation, 1986
- INHIBITION OF THE ACCESSORY FUNCTION OF MURINE MACROPHAGES IN VITRO BY CYCLOSPORINETransplantation, 1985
- Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin AScience, 1984
- Expression of HLA-DR Antigen in Skin from Patients with PsoriasisJournal of Investigative Dermatology, 1982